According to the FDA, Ascend Laboratories LLC, headquartered in Parsippany, New Jersey, has voluntarily recalled its Dabigatran Etexilate Capsules, USP, 75 mg and 150 mg, to the consumer level. The move was announced on March 22, 2023, after the product was found to contain a […]
Mar 23, 2023
By TruLaw